Symeres
2 known investors
Symeres is a contract research organization providing integrated drug discovery and development services—spanning medicinal and synthetic chemistry, biology, ADME-tox, drug delivery, preclinical, and CMC/GMP manufacturing—from initial idea through IND. It serves biotech and pharma clients across Europe and North America through nine connected sites.
BiotechHealthtech
Investors · 2
Frequently asked questions
- What does Symeres do?
- Symeres is a contract research organization providing integrated drug discovery and development services—spanning medicinal and synthetic chemistry, biology, ADME-tox, drug delivery, preclinical, and CMC/GMP manufacturing—from initial idea through IND. It serves biotech and pharma clients across Europe and North America through nine connected sites.
- Who are Symeres's investors?
- Symeres's investors include Gilde Healthcare, Keensight Capital.